SCHEMBL12235665

SCHEMBL12235665

Cc1nc2c(=O)[nH]cnc2nc1O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.47
▸ HPGD P15428 4/20 0.47
▸ KDM4E B2RXH2 3/20 0.47
▸ HSD17B10 Q99714 3/20 0.47
▸ GAA P10253 2/20 0.47
▸ TSHR P16473 1/20 0.47
▸ HTT P42858 1/20 0.47
▸ XDH P47989 1/20 0.40
▸ PDPK1 O15530 2/20 0.38
▸ PARP1 P09874 2/20 0.37
▸ BCL2 P10415 1/20 0.37
▸ MCL1 Q07820 1/20 0.37
▸ RAB9A P51151 2/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ TP53 P04637 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ BCAT2 O15382 1/20 0.36
▸ GDA Q9Y2T3 1/20 0.35
▸ PNP P00491 1/20 0.34
▸ SRC P12931 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12235799 0.93 ALDH1A1 (0.47) ALDH1A1HPGDKDM4EHSD17B10GAA
SCHEMBL13187309 0.85 ALDH1A1 (0.53) ALDH1A1HPGDKDM4EHSD17B10GAA
SCHEMBL13187699 0.76 HPGD (0.47) ALDH1A1HPGDKDM4EHSD17B10GAA
SCHEMBL24629159 0.71 ALDH1A1 (0.52) ALDH1A1HPGDKDM4EHSD17B10GAA
SCHEMBL18779094 0.71 KDM4E (0.48) ALDH1A1HPGDKDM4EHSD17B10GAA
SCHEMBL13981736 0.68 ALDH1A1 (0.63) ALDH1A1HPGDKDM4EHSD17B10GAA
SCHEMBL6765002 0.67 — —
SCHEMBL12138872 0.67 — —
Hypoxanthine SCHEMBL28275707 0.65 ALDH1A1 (0.86) ALDH1A1HSD17B10TSHRXDHPDPK1
SCHEMBL16984409 0.64 XDH (0.49) ALDH1A1HPGDKDM4EHSD17B10GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110263540-A1 SMALL-MOLECULE INHIBITORS OF PROTEIN SYNTHESIS INACTIVATING TOXINS MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH 2011-10-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110263540-A1 SMALL-MOLECULE INHIBITORS OF PROTEIN SYNTHESIS INACTIVATING TOXINS MRPS27, MRPS22, MRPS23 ALDH1A1 4637/4885HPGD 3921/4885KDM4E 3689/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback